共 87 条
- [1] Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection[J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (11) : 1449 - 1455Almyroudis, Nikolaos G.Kontoyiannis, Dimitrios P.Sepkowitz, Kent A.DePauw, Ben E.Walsh, Thomas J.Segal, Brahm H.
- [2] ALSH TJ, 2003, J INFECT DIS, V188, P305
- [3] Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) : 606 - 611Anaissie, EJMattiuzzi, GNMiller, CBNoskin, GAGurwith, MJMamelok, RDPietrelli, LA
- [4] Clinical research in the lay press: Irresponsible journalism raises a huge dose of doubt[J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (08) : 1031 - 1039Anaissie, Elias J.Segal, Brahm H.Graybill, John R.Arndt, CarolaPerfect, John R.Kleinberg, MichaelPappas, PeterBenjamin, DannyRubin, RobertAberg, Judith A.Adderson, Elisabeth E.Adler-Shohet, Felice C.Akan, HamdiAkova, MuratAlmyroudis, Nikolaos G.Alexander, Barbara D.Andes, DavidArrieta, AntonioBaddley, John W.Barron, Michelle A.Belzberg, HowardBoucher, Helen W.Boyce, Thomas G.Casadevall, ArturoChandrasekar, P. H.Cleary, John D.Cordonnier, CatherineCornely, Oliver A.Cuenca-Estrella, ManuelDaly, Jennifer S.Daoura, NicholasDenning, David W.dePauw, Bende Repentigny, LouisDignani, Maria CeciliaDismukes, William E.Donnelly, J. PeterDonowitz, Gerald R.Dupont, BertrandDrusano, GeorgeEllis, MichaelEspinel-Ingroff, AnaFishman, Jay A.Fleming, RhondaForrest, GraemeGhannoum, MahmoudGoldman, MitchellGrazziutti, MonicaGreene, John N.Greenberg, Richard N.
- [5] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus[J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 7 - 14Ascioglu, SRex, JHde Pauw, BBennett, JEBille, JCrokaert, FDenning, DWDonnelly, JPEdwards, JEErjavec, ZFiere, DLortholary, OMaertens, JMeis, JFPatterson, TFRitter, JSelleslag, DShah, PMStevens, DAWalsh, TJ
- [6] Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (03) : 448 - 457Becker, MJLugtenburg, EJCornelissen, JJvan der Schee, CHoogsteden, HCde Marie, S
- [7] Invasive aspergillosis in allogeneic stem cell transplant recipients: Increasing antigenemia is associated with progressive disease[J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) : 939 - 943Boutboul, FAlberti, CLeblanc, TSulahian, AGluckman, EDerouin, FRibaud, P
- [8] A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients[J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) : 359 - 366Bowden, RChandrasekar, PWhite, MHLi, XPietrelli, LGurwith, Mvan Burik, JALaverdiere, MSafrin, SWingard, JR
- [9] Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis[J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1407 - 1412Bretagne, SCosta, JMBart-Delabesse, EDhédin, NRieux, CCordonnier, C
- [10] Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients[J]. JOURNAL OF INFECTION, 1997, 35 (01) : 7 - 15Bretagne, SMarmoratKhuong, AKuentz, MLatge, JPBartDelabesse, ECordonnier, C